University · founded 1864
University of Health Sciences and Pharmacy
St Louis, United States · uhsp.edu
- Citations, last 5 years
- 4 449
- Works, last 5 years
- 473
- h-index
- 106
- Scientists listed
- 47
- Grants since 2016
- 40
Grants received
2025–2026 · research · R61
Multipurpose Device for Female-initiated Nonsteroidal On-Demand Contraception
Giovanni M Pauletti · University of Health Sciences and Pharmacy · funded by National Institutes of Health
2022–2025 · research · R15
Iron Metabolism in Ts65Dn mice, a Model of Down syndrome
Keith C Deruisseau · University of Health Sciences and Pharmacy · funded by National Institutes of Health
2022–2025 · research · R21
Investigation and Targeting of Alternate Binding Site in ERRα
Lamees Hegazy · University of Health Sciences and Pharmacy · funded by National Institutes of Health
2022–2026 · research · R21
Investigation and Targeting of Alternate Binding Site in ERRα
Lamees Hegazy · University of Health Sciences and Pharmacy · funded by National Institutes of Health
2022–2025 · research · R21
Investigation and Targeting of Alternate Binding Site in ERRα
Lamees Hegazy · University of Health Sciences and Pharmacy · funded by National Institutes of Health
2022–2027 · research · R01
Peripheral Mechanisms of Kappa Opioid Receptor-Mediated Cold Hypersensitivity
Ream Al-Hasani · University of Health Sciences and Pharmacy · funded by National Institutes of Health
2022–2027 · research · R01
Developing Chemical Probes for Inflammatory Pain
Bahaa Elgendy · University of Health Sciences and Pharmacy · funded by National Institutes of Health
2022–2023 · research · R01
Developing Chemical Probes for Inflammatory Pain
Bahaa Elgendy · University of Health Sciences and Pharmacy · funded by National Institutes of Health
2022–2024 · research · R01
Peripheral Mechanisms of Kappa Opioid Receptor-Mediated Cold Hypersensitivity
Ream Al-Hasani · University of Health Sciences and Pharmacy · funded by National Institutes of Health
2021–2023 · research · R34
Synthesis of peripherally active CB1 agonists as analgesics
Ron Dror · University of Health Sciences and Pharmacy · funded by National Institutes of Health
2020–2023 · research · R21
Development of Novel ERRa Selective Agonists as Chemical Probes for the Potential Treatment of Alzheimer's Disease
Bahaa Elgendy · University of Health Sciences and Pharmacy · funded by National Institutes of Health
2020–2024 · research · R21
Heart and vascular responses across the lifespan in Ts65Dn mice, a model of Down syndrome
Lara Roberts Deruisseau · University of Health Sciences and Pharmacy · funded by National Institutes of Health
2019–2024 · research · R33
SMART Polymer Fibers For Tampon-Like Nonsteroidal Contraceptive Devices
Giovanni M Pauletti · University of Health Sciences and Pharmacy · funded by National Institutes of Health
2019–2020 · research · R01
Development of RORalpha and RORgamma Ligands for Treatment of Behavioral Disorders
Thomas P Burris · University of Health Sciences and Pharmacy · funded by National Institutes of Health
2019–2025 · research · R33
SMART Polymer Fibers For Tampon-Like Nonsteroidal Contraceptive Devices
Giovanni M Pauletti · University of Health Sciences and Pharmacy · funded by National Institutes of Health
2019–2025 · research · R33
SMART Polymer Fibers For Tampon-Like Nonsteroidal Contraceptive Devices
Giovanni M Pauletti · University of Health Sciences and Pharmacy · funded by National Institutes of Health
2019–2021 · research · R61
SMART Polymer Fibers For Tampon-Like Nonsteroidal Contraceptive Devices
Giovanni M Pauletti · University of Health Sciences and Pharmacy · funded by National Institutes of Health
2019–2021 · research · R61
SMART Polymer Fibers For Tampon-Like Nonsteroidal Contraceptive Devices
Giovanni M Pauletti · University of Health Sciences and Pharmacy · funded by National Institutes of Health
2019–2023 · grant · PRMRP
REV-ERB Antagonists for Treatment of Muscle Injuries
Bahaa El-Gendy · University of Health Sciences and Pharmacy · funded by Congressionally Directed Medical Research Programs
2019–2022 · research · R21
Rapid and sensitive in vivo detection of opioid peptides
Ream Al-Hasani · University of Health Sciences and Pharmacy · funded by National Institutes of Health
2019–2021 · research · R21
Rapid and sensitive in vivo detection of opioid peptides
Ream Al-Hasani · University of Health Sciences and Pharmacy · funded by National Institutes of Health
2019–2024 · research · R33
SMART Polymer Fibers For Tampon-Like Nonsteroidal Contraceptive Devices
Giovanni M Pauletti · University of Health Sciences and Pharmacy · funded by National Institutes of Health
2019–2021 · research · RF1
Targeting REV-ERB to treat Alzheimer's disease
Thomas P Burris · University of Health Sciences and Pharmacy · funded by National Institutes of Health
2018–2022 · research · R33
Pharmacological Probes based on mitragynine pseudoindoxyl
Susruta Majumdar · University of Health Sciences and Pharmacy · funded by National Institutes of Health
2018–2020 · research · R21
Pharmacological Probes based on mitragynine pseudoindoxyl
Susruta Majumdar · University of Health Sciences and Pharmacy · funded by National Institutes of Health
2018–2022 · fellowship · F32
Targeting REV-ERB regulation of mitochondria as a therapeutic strategy in Alzheimer's disease
Jaymie Voorhees · University of Health Sciences and Pharmacy · funded by National Institutes of Health
2018–2021 · fellowship · F32
Targeting REV-ERB regulation of mitochondria as a therapeutic strategy in Alzheimer's disease
Jaymie Voorhees · University of Health Sciences and Pharmacy · funded by National Institutes of Health
2018–2021 · fellowship · F32
Targeting REV-ERB regulation of mitochondria as a therapeutic strategy in Alzheimer's disease
Jaymie Voorhees · University of Health Sciences and Pharmacy · funded by National Institutes of Health
2018–2020 · research · R21
Pharmacological Probes based on mitragynine pseudoindoxyl
Susruta Majumdar · University of Health Sciences and Pharmacy · funded by National Institutes of Health
2018–2022 · fellowship · F32
Targeting REV-ERB regulation of mitochondria as a therapeutic strategy in Alzheimer's disease
Jaymie Voorhees · University of Health Sciences and Pharmacy · funded by National Institutes of Health
2018–2022 · research · R33
Pharmacological Probes based on mitragynine pseudoindoxyl
Susruta Majumdar · University of Health Sciences and Pharmacy · funded by National Institutes of Health
2017–2020 · fellowship · Scientist Development Grant
Investigating the LXR-Acat2 Connection for the Treatment of Atherosclerosis
Kristine Griffett · University of Health Sciences and Pharmacy · funded by American Heart Association
2017–2020 · research · R00
DEFINING DYNORPHIN-CRF CIRCUITS IN STRESS AND NICOTINE BEHAVIORS
Ream Al-Hasani · University of Health Sciences and Pharmacy · funded by National Institutes of Health
2017–2020 · research · R00
DEFINING DYNORPHIN-CRF CIRCUITS IN STRESS AND NICOTINE BEHAVIORS
Ream Al-Hasani · University of Health Sciences and Pharmacy · funded by National Institutes of Health
2017–2021 · research · R00
DEFINING DYNORPHIN-CRF CIRCUITS IN STRESS AND NICOTINE BEHAVIORS
Ream Al-Hasani · University of Health Sciences and Pharmacy · funded by National Institutes of Health
2016–2020 · grant · PRMRP
Peripherally Restricted to REV-ERB Agonists for Treatment of Diabetes and Obesity
Thomas Burris · University of Health Sciences and Pharmacy · funded by Congressionally Directed Medical Research Programs
2016–2020 · research · R01
ERRgamma Agonists to Treat Muscular Dystrophy
Thomas P Burris · University of Health Sciences and Pharmacy · funded by National Institutes of Health
2010–2022 · research · R01
Development of RORalpha and RORgamma Ligands for Treatment of Behavioral Disorders
Thomas P Burris · University of Health Sciences and Pharmacy · funded by National Institutes of Health
2010–2021 · research · R01
Development of RORalpha and RORgamma Ligands for Treatment of Behavioral Disorders
Thomas P Burris · University of Health Sciences and Pharmacy · funded by National Institutes of Health
2010–2021 · research · R01
Development of RORalpha and RORgamma Ligands for Treatment of Behavioral Disorders
Thomas P Burris · University of Health Sciences and Pharmacy · funded by National Institutes of Health
